| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 06/12/2018 | 23h10 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 06/12/2018 | 22h18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/12/2018 | 23h53 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/12/2018 | 23h49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 13/11/2018 | 23h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 13/11/2018 | 23h01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 13/11/2018 | 23h00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 13/11/2018 | 22h59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/11/2018 | 23h09 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/11/2018 | 22h19 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 09/11/2018 | 22h17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 30/10/2018 | 21h32 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/10/2018 | 22h59 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 26/10/2018 | 22h18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 24/10/2018 | 23h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 24/10/2018 | 23h04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 02/10/2018 | 22h57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2018 | 23h02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2018 | 23h01 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2018 | 23h00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 25/09/2018 | 22h59 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 24/09/2018 | 22h20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 18/09/2018 | 22h57 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 04/09/2018 | 22h46 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 17/08/2018 | 13h01 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/08/2018 | 23h06 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 14/08/2018 | 23h00 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 07/08/2018 | 23h04 | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 03/08/2018 | 23h22 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |
| 03/08/2018 | 22h18 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ONS | Oncobiologics, Inc. (delisted) |